Skip to content

The role of clinical pharmacists' intervention on improving the adherence to treatment and clinical outcomes among hemodialysis patients

The role of clinical pharmacist in enhancing hemodialysis patients’ adherence and clinical outcomes: a randomized-controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN75517095
Enrollment
120
Registered
2022-03-25
Start date
2021-05-01
Completion date
Unknown
Last updated
2022-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adherence to treatment in dialysis patients Urological and Genital Diseases

Interventions

Using stratified sampling based on age and gender, eligible patients were randomly assigned to intervention or control groups. The intervention group will receive an educational instructional session

Sponsors

Jordan University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. At least 18 years old 2. Been on continuous HD for at least three months 3. Stable medical condition

Exclusion criteria

Exclusion criteria: 1. Mental disease 2. Malignancies 3. Acute illness 4. Terminally ill 5. Under irregular dialysis

Design outcomes

Primary

MeasureTime frame
Overall adherence to treatment recommendations assessed using a previously validated ESRD-AQ tool. This was assessed at baseline and after three months of follow up

Secondary

MeasureTime frame
1. Quality of life measured using KDQOLTM-36 at baseline and after three months of follow up 2. Disease awareness measured using interview with clinical pharmacist at baseline and after three months of follow up 3. Number of emergency or hospital admissions measured using patient records for three months of follow up 4. Biochemical measurements included serum levels of sodium, potassium, urea, creatinine, albumin, hemoglobin level, calcium, phosphorus, and PTH which were obtained from patients' medical records at baseline and after three months of follow up

Countries

Jordan

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 17, 2026